| 标题 |
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Neurology 作者:Marcelo E Bigal; David W Dodick; Alan M Rapoport; Stephen D Silberstein; Yuju Ma; et al 出版日期:2015-10-02 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)